Operates two reported segments on BSE — a small Healthcare (biotech/nutrition) business and rental income from a leasehold land holding — and is classified under Commodity Chemicals. In FY26, revenue from operations (the Healthcare segment) fell about 39% year-on-year to ₹37.08 lakh from ₹61.09 lakh, while total income of ₹240.66 lakh was supported by ₹165.31 lakh of rent on leasehold land booked as other income. Segment data for the year ending March 2026 shows Healthcare at ₹0.0928 crore, Rent on Leasehold Land at ₹0.4133 crore and Others at ₹0.0601 crore of period segment revenue. Profit after tax nevertheless rose 37.8% to ₹43.59 lakh (from ₹31.62 lakh) largely because the tax expense dropped from ₹64.20 lakh to ₹14.37 lakh. The company carries no debt and holds total assets of ₹9.5301 crore; employee cost of ₹1.0791 crore is several times its revenue from operations, indicating the core biotech activity is a very small contributor relative to fixed costs. AR · MarketPing reader · 2026-08-03
Revenue streams, as the annual report describes them. Healthcare, Rent on Leasehold land, Others. Very small BSE-listed entity with a declining biotech core propped up by steady leasehold rent income; low operating scale, no debt.
| ₹ crore · consolidated |
|---|
| Revenue |
| EBITDA (ex other income) |
| margin % |
| Owners' profit |
| EPS, as reported (₹) |
| ROE % · ROCE % |
| Debt / equity (x) |
| Cash from operations |
| Capex |
| ₹ crore | Q1 FY27 |
|---|---|
| Revenue | 0 |
| Profit before tax | 0 |
| Net profit | 0 |
| EPS (₹) | 0.26 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| DEEPAK FERTILIZERS & PETR | 16,727 | 17.0 | 2.24 | 12.2 | 9.9 | 8.4 | 14.6 | 26.1 |
| TATA CHEMICALS LTD | 15,683 | — | 0.71 | 141.2 | (7.7) | (5.0) | 7.4 | 14.4 |
| GUJ NAR VAL FER & CHEM L | 8,273 | 8.0 | 0.91 | 6.0 | 8.9 | 10.3 | 8.7 | 22.1 |
| TANFAC INDUSTRIES LTD. | 6,773 | 55.4 | 18.15 | — | 18.8 | 24.3 | — | 16.0 |
| GUJARAT ALKALIES & CHEM | 5,179 | 78.0 | 1.00 | 10.7 | (0.0) | 0.7 | 12.4 | 18.4 |
| GHCL LIMITED | 3,879 | 8.4 | 1.09 | 5.1 | 13.3 | 16.6 | 1.1 | 23.9 |
| GRAUER & WEIL IND LTD | 3,469 | 21.2 | 3.21 | 14.1 | 15.2 | 19.2 | 14.5 | 20.4 |
| J.G.CHEMICALS LIMITED | 2,330 | 31.0 | 4.31 | 23.7 | 12.7 | 16.9 | — | 11.5 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 5 Sept 2026 · Newspaper ads confirming 34th AGM notice filed with BSE | compliance | minimal | — | — |
| 4 Sept 2026 · Annual Report and AGM Notice sent to shareholders without registered email | compliance | minimal | — | — |
| 4 Sept 2026 · Letter to shareholders without registered email about 34th AGM and Annual Report | compliance | minimal | — | — |
| 4 Sept 2026 · Annual Report and AGM Notice for FY2025-26 submitted | results | high | — | — |
| 4 Sept 2026 · Notice of 34th AGM on Sept 29, 2026; re-appointment of MD and WTD | board shareholder meetings | low | — | — |
| 27 Aug 2026 · Newspaper notice for 34th AGM via video conferencing on Sept 29 | compliance | minimal | — | — |
| 8 Aug 2026 · Newspaper publication of Q1 FY27 audited results filed with BSE | compliance | minimal | — | — |
| 7 Aug 2026 · Q1 FY27 Results: Revenue declines 36% YoY, PAT at Rs 13.15 lakh | results | high | — | — |
| 7 Aug 2026 · Q1 FY27 results: Core revenue declines, profit holds steady | results | medium | — | — |
| 1 Aug 2026 · Board meeting on Aug 7 to approve Q1 FY27 financial results | results | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 90.7 | 17.0 | 55 of 57 | 4% |
| EBITDA margin | 314.3 | 13.3 | 3 of 58 | 97% |
| Market cap | 12 | 77 | 56 of 65 | 14% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
